Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Regencell Bioscience Holdings Limited - Ordinary Shares (NQ:RGC)

29.28 +1.69 (+6.13%)
Streaming Delayed Price Updated: 10:40 AM EDT, May 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 45,851
Open 27.50
Bid (Size) 28.47 (200)
Ask (Size) 29.50 (100)
Prev. Close 27.59
Today's Range 27.40 - 29.28
52wk Range 2.622 - 83.60
Shares Outstanding 13,012,866
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Kaplan Fox Continues to Alert Investors of Regencell Bioscience Holdings Limited (NASDAQ: RGC) to a Class Action Deadline on June 23, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Law Enforcement Lawsuit
News headline image
Kaplan Fox Continues to Alert Investors of Regencell Bioscience Holdings Limited (NASDAQ: RGC) to a Class Action Deadline on June 23, 2026
NEW YORK, NY - May 7, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Regencell Bioscience Holdings Limited (“Regencell” or the “Company”)... 
Via TheNewswire.com
Topics Law Enforcement Lawsuit

Performance

YTD
+42.6%
+42.6%
1 Month
-5.0%
-5.0%
3 Month
+3.2%
+3.2%
6 Month
+123.5%
+123.5%
1 Year
+636.8%
+636.8%

More News

Read More
News headline image
REGENCELL CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Regencell Bioscience Holdings Limited and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
ROSEN, LEADING INVESTOR COUNSEL, Encourages Regencell Bioscience Holdings Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action – RGC
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm Encourages Regencell Bioscience Holdings Limited (RGC) Shareholders To Inquire About Securities Fraud Class Action
From Glancy Prongay Wolke & Rotter LLP
Via Business Wire
News headline image
RGC CLASS ACTION DEADLINE: Kaplan Fox Encourages Investors of Regencell Bioscience Holdings Limited (NASDAQ: RGC) to Contact the Firm Before the Lead Plaintiff Deadline on June 13, 2026
Via NewMediaWire
Topics Law Enforcement Lawsuit
News headline image
RGC CLASS ACTION DEADLINE: Kaplan Fox Encourages Investors of Regencell Bioscience Holdings Limited (NASDAQ: RGC) to Contact the Firm Before the Lead Plaintiff Deadline on June 13, 2026
Via TheNewswire.com
Topics Law Enforcement Lawsuit
News headline image
Pomerantz Law Firm Announces the Filing of a Class Action Against Regencell Bioscience Holdings Limited and Certain Officers – RGC
From Pomerantz LLP
Via GlobeNewswire
News headline image
RGC Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Regencell Bioscience Holdings Securities Lawsuit - Contact Levi & Korsinsky
From Levi & Korsinsky, LLP
Via Business Wire
News headline image
Law Offices of Howard G. Smith Encourages Regencell Bioscience Holdings Limited (RGC) Shareholders To Inquire About Securities Fraud Class Action
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
RGC Investors Have Opportunity to Lead Regencell Bioscience Holdings Limited Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
Law Offices of Frank R. Cruz Encourages Regencell Bioscience Holdings Limited (RGC) Shareholders To Inquire About Securities Fraud Class Action
From Law Offices of Frank R. Cruz
Via Business Wire
News headline image
Regencell Bioscience Holdings Limited (NASDAQ: RGC) Investors Have Until June 23, 2026 to Seek a Leadership Role in the Securities Class Action Lawsuit Contact Kaplan Fox & Kilsheimer LLP
Via NewMediaWire
Topics Law Enforcement Lawsuit
News headline image
Regencell Bioscience Holdings Limited (NASDAQ: RGC) Investors Have Until June 23, 2026 to Seek a Leadership Role in the Securities Class Action Lawsuit Contact Kaplan Fox & Kilsheimer LLP
Via TheNewswire.com
Topics Law Enforcement Lawsuit
News headline image
REGENCELL BIOSCIENCE DEADLINE FOR LEADERSHIP is June 23, 2026 in a Securities Fraud Lawsuit - Investors Encouraged to Contact Kaplan Fox
Via NewMediaWire
Topics Fraud Law Enforcement Lawsuit
News headline image
REGENCELL BIOSCIENCE DEADLINE FOR LEADERSHIP is June 23, 2026 in a Securities Fraud Lawsuit - Investors Encouraged to Contact Kaplan Fox
Via TheNewswire.com
Topics Fraud Law Enforcement Lawsuit
News headline image
Deadline to Lead in Securities Fraud Lawsuit Against Regencell Bioscience Holdings Limited (RGC) is June 23, 2026 - Contact Kaplan Fox
Via NewMediaWire
Topics Fraud Law Enforcement Lawsuit
News headline image
Deadline to Lead in Securities Fraud Lawsuit Against Regencell Bioscience Holdings Limited (RGC) is June 23, 2026 - Contact Kaplan Fox
Via TheNewswire.com
Topics Fraud Law Enforcement Lawsuit
News headline image
Securities Fraud Investigation Into Regencell Bioscience Holdings Limited (RGC) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
From Glancy Prongay Wolke & Rotter LLP
Via Business Wire
News headline image
Kaplan Fox Encourages Investors of Regencell Bioscience Holdings Limited (NASDAQ: RGC) to Contact the Firm Before Lead Plaintiff Deadline on June 23, 2026
Via TheNewswire.com
Topics Law Enforcement Lawsuit
News headline image
Kaplan Fox Encourages Investors of Regencell Bioscience Holdings Limited (NASDAQ: RGC) to Contact the Firm Before Lead Plaintiff Deadline on June 23, 2026
Via NewMediaWire
Topics Law Enforcement Lawsuit
News headline image
Regencell Bioscience Holdings Limited (RGC) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
Kaplan Fox Alerts Regencell Bioscience Holdings Limited (RGC) Investors of June 23, 2026 Lead Plaintiff Deadline in Securities Class Action Case
Via NewMediaWire
Topics Law Enforcement Lawsuit
News headline image
Kaplan Fox Alerts Regencell Bioscience Holdings Limited (RGC) Investors of June 23, 2026 Lead Plaintiff Deadline in Securities Class Action Case
Via TheNewswire.com
Topics Law Enforcement Lawsuit
News headline image
Securities Fraud Investigation Into Regencell Bioscience Holdings Limited (RGC) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
From The Law Offices of Frank R. Cruz
Via Business Wire

Frequently Asked Questions

Is Regencell Bioscience Holdings Limited - Ordinary Shares publicly traded?
Yes, Regencell Bioscience Holdings Limited - Ordinary Shares is publicly traded.
What exchange does Regencell Bioscience Holdings Limited - Ordinary Shares trade on?
Regencell Bioscience Holdings Limited - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Regencell Bioscience Holdings Limited - Ordinary Shares?
The ticker symbol for Regencell Bioscience Holdings Limited - Ordinary Shares is RGC on the Nasdaq Stock Market
What is the current price of Regencell Bioscience Holdings Limited - Ordinary Shares?
The current price of Regencell Bioscience Holdings Limited - Ordinary Shares is 29.28
When was Regencell Bioscience Holdings Limited - Ordinary Shares last traded?
The last trade of Regencell Bioscience Holdings Limited - Ordinary Shares was at 05/07/26 10:40 AM ET
What is the market capitalization of Regencell Bioscience Holdings Limited - Ordinary Shares?
The market capitalization of Regencell Bioscience Holdings Limited - Ordinary Shares is 381.02M
How many shares of Regencell Bioscience Holdings Limited - Ordinary Shares are outstanding?
Regencell Bioscience Holdings Limited - Ordinary Shares has 381M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.